Letters to the Editor

Clinicopathological and genetic features of limited-stage diffuse large B-cell lymphoma with late relapse: targeted sequencing analysis of gene alterations in the initial and late relapsed tumors

Department of Hematology, National Cancer Center Hospital, Tokyo, Japan;
Department of Hematology, National Cancer Center Hospital, Tokyo, Japan;
Department of Hematology, National Cancer Center Hospital, Tokyo, Japan;
Department of Epigenomics, National Cancer Center Research Institute, Tokyo, Japan;
Department of Pathology, National Cancer Center Hospital, Tokyo, Japan
Department of Hematology, National Cancer Center Hospital, Tokyo, Japan;
Department of Hematology, National Cancer Center Hospital, Tokyo, Japan;
Department of Hematology, National Cancer Center Hospital, Tokyo, Japan;
Department of Hematology, National Cancer Center Hospital, Tokyo, Japan;
Department of Hematology, National Cancer Center Hospital, Tokyo, Japan;
Department of Hematology, National Cancer Center Hospital, Tokyo, Japan;
Department of Hematology, National Cancer Center Hospital, Tokyo, Japan;
Department of Pathology, National Cancer Center Hospital, Tokyo, Japan
Department of Epigenomics, National Cancer Center Research Institute, Tokyo, Japan;
Department of Hematology, National Cancer Center Hospital, Tokyo, Japan;
Department of Hematology, National Cancer Center Hospital, Tokyo, Japan;
Department of Hematology, National Cancer Center Hospital, Tokyo, Japan;
Haematologica Early view Mar 26, 2020 https://doi.org/10.3324/haematol.2019.235598